Krystal Biotech (KRYS) Free Cash Flow Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 24.91% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 14.71% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -10.65% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 31.42% |
| 10 | Krystal Biotech | 9.05 Bn | 8.23 Bn | 110.03 Mn | 57.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.76% |
| Dec 31, 2025 | 75.65% |
| Sep 30, 2025 | 238.05% |
| Jun 30, 2025 | 39.92% |
| Mar 31, 2025 | 44.00% |
| Dec 31, 2024 | 99.22% |
| Sep 30, 2024 | 59.36% |
| Jun 30, 2024 | 28.78% |
| Mar 31, 2024 | 37.61% |
| Dec 31, 2023 | 32.28% |
| Sep 30, 2023 | -24.85% |
| Jun 30, 2023 | -66.60% |
| Mar 31, 2023 | -71.57% |
| Dec 31, 2022 | -21.06% |
| Sep 30, 2022 | 36.30% |
| Jun 30, 2022 | -144.51% |
| Mar 31, 2022 | -105.08% |
| Dec 31, 2021 | -22.25% |
| Sep 30, 2021 | -116.80% |
| Jun 30, 2021 | -105.18% |
| Mar 31, 2021 | -73.01% |
| Dec 31, 2020 | -88.17% |
| Sep 30, 2020 | -114.53% |
| Jun 30, 2020 | -153.95% |
| Mar 31, 2020 | -205.52% |
| Dec 31, 2019 | -142.28% |